In studies focused on hepatocellular carcinoma and melanoma, elevated expression of specific EIF3 subunits (B and F) has been demonstrated to directly or indirectly suppress CD8+ T cell infiltration and impair the efficacy of PD-1 blockade therapy (Zhou et al., 2025; Wu et al., 2022). Here, EIF3A is linked to hepatocellular carcinoma.